Japan’s Eisai Gets EU Nod for Thyroid Cancer Drug

31.03.2015 - The EU's Committee for Medicinal Products for Human Use (CHMP) has recommended the use of Eisai's Lenvima (Lenvatinib mesylate) drug for treating adults with progressive, locally...